These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. Dysken MW; Sano M; Asthana S; Vertrees JE; Pallaki M; Llorente M; Love S; Schellenberg GD; McCarten JR; Malphurs J; Prieto S; Chen P; Loreck DJ; Trapp G; Bakshi RS; Mintzer JE; Heidebrink JL; Vidal-Cardona A; Arroyo LM; Cruz AR; Zachariah S; Kowall NW; Chopra MP; Craft S; Thielke S; Turvey CL; Woodman C; Monnell KA; Gordon K; Tomaska J; Segal Y; Peduzzi PN; Guarino PD JAMA; 2014 Jan; 311(1):33-44. PubMed ID: 24381967 [TBL] [Abstract][Full Text] [Related]
5. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia. Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903 [TBL] [Abstract][Full Text] [Related]
6. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. Wilcock GK; Ballard CG; Cooper JA; Loft H J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023 [TBL] [Abstract][Full Text] [Related]
7. Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis. Kishi T; Matsunaga S; Oya K; Nomura I; Ikuta T; Iwata N J Alzheimers Dis; 2017; 60(2):401-425. PubMed ID: 28922160 [TBL] [Abstract][Full Text] [Related]
8. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials. Tsoi KK; Hirai HW; Chan JY; Kwok TC J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193 [TBL] [Abstract][Full Text] [Related]
9. Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer's disease: a cumulative meta-analysis and trial sequential analysis. Blanco-Silvente L; Castells X; Garre-Olmo J; Vilalta-Franch J; Saez M; Barceló MA; Capellà D Eur J Clin Pharmacol; 2019 Dec; 75(12):1659-1667. PubMed ID: 31435707 [TBL] [Abstract][Full Text] [Related]
10. Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients. Blanco-Silvente L; Castells X; Saez M; Barceló MA; Garre-Olmo J; Vilalta-Franch J; Capellà D Int J Neuropsychopharmacol; 2017 Jul; 20(7):519-528. PubMed ID: 28201726 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis. Matsunaga S; Kishi T; Iwata N Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25548104 [TBL] [Abstract][Full Text] [Related]
13. The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis. Livingston G; Katona C Int J Geriatr Psychiatry; 2004 Oct; 19(10):919-25. PubMed ID: 15449303 [TBL] [Abstract][Full Text] [Related]